A novel animal model of pruritus induced by successive application of glucocorticoid to mouse skin

Katsunori Yamaura, Ryosuke Doi, Eriko Suwa, Koichi Ueno

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Topical glucocorticoids are commonly applied for treatment of atopic dermatitis, and are often administered over a long period. However, itching often occurs as a rebound phenomenon after cessation of long-term glucocorticoid application. The present study was an initial trial designed to establish an animal model of glucocorticoid-induced pruritus by topical application of dexamethasone over a long period in mice with contact dermatitis. BALB/c mice with chronic allergic contact dermatitis induced by 5 weeks of repeated application of 2,4,6-trinitro-1-chlorobenzene (TNCB) were treated topically with dexamethasone for 3 weeks from 2 weeks after the elicitation of dermatitis. The effects of dexamethasone on inflammation and pruritus were evaluated by measurement of ear-swelling and scratching behavior, respectively. Significant enhancement of pruritus was confirmed after chronic application of dexamethasone. The increased frequency of scratching behavior was reduced by withdrawal of dexamethasone. On the other hand, ear-swelling was markedly ameliorated by dexamethasone treatment, but rapidly relapsed after dexamethasone withdrawal. The level of interleukin (IL)-4 mRNA in ear skin and that of IgE in serum were increased in the mice with dermatitis and reduced by dexamethasone treatment. On the other hand, the level of nerve growth factor (NGF) mRNA was slightly increased by dexamethasone treatment and remained high even after its discontinuation. It is anticipated that this novel animal model of glucocorticoid-induced pruritus will be useful for clarifying the mechanisms of the rebound phenomenon induced by chronic treatment with topical glucocorticoids, and for developing a new form of therapy.

Original languageEnglish
Pages (from-to)395-401
Number of pages7
JournalJournal of Toxicological Sciences
Volume36
Issue number4
DOIs
Publication statusPublished - 2011 Aug
Externally publishedYes

Fingerprint

Pruritus
Dexamethasone
Glucocorticoids
Skin
Animals
Animal Models
Dermatitis
Ear
Swelling
Picryl Chloride
Messenger RNA
Allergic Contact Dermatitis
Contact Dermatitis
Nerve Growth Factor
Atopic Dermatitis
Interleukin-4
Immunoglobulin E
Inflammation
Serum

Keywords

  • Contact dermatitis
  • Dexamethasone
  • Nerve growth factor mRNA
  • Pruritus
  • Serum IgE
  • Topical glucocorticoid

ASJC Scopus subject areas

  • Toxicology

Cite this

A novel animal model of pruritus induced by successive application of glucocorticoid to mouse skin. / Yamaura, Katsunori; Doi, Ryosuke; Suwa, Eriko; Ueno, Koichi.

In: Journal of Toxicological Sciences, Vol. 36, No. 4, 08.2011, p. 395-401.

Research output: Contribution to journalArticle

@article{dd2ac51f97e344a99ac9423d117c3422,
title = "A novel animal model of pruritus induced by successive application of glucocorticoid to mouse skin",
abstract = "Topical glucocorticoids are commonly applied for treatment of atopic dermatitis, and are often administered over a long period. However, itching often occurs as a rebound phenomenon after cessation of long-term glucocorticoid application. The present study was an initial trial designed to establish an animal model of glucocorticoid-induced pruritus by topical application of dexamethasone over a long period in mice with contact dermatitis. BALB/c mice with chronic allergic contact dermatitis induced by 5 weeks of repeated application of 2,4,6-trinitro-1-chlorobenzene (TNCB) were treated topically with dexamethasone for 3 weeks from 2 weeks after the elicitation of dermatitis. The effects of dexamethasone on inflammation and pruritus were evaluated by measurement of ear-swelling and scratching behavior, respectively. Significant enhancement of pruritus was confirmed after chronic application of dexamethasone. The increased frequency of scratching behavior was reduced by withdrawal of dexamethasone. On the other hand, ear-swelling was markedly ameliorated by dexamethasone treatment, but rapidly relapsed after dexamethasone withdrawal. The level of interleukin (IL)-4 mRNA in ear skin and that of IgE in serum were increased in the mice with dermatitis and reduced by dexamethasone treatment. On the other hand, the level of nerve growth factor (NGF) mRNA was slightly increased by dexamethasone treatment and remained high even after its discontinuation. It is anticipated that this novel animal model of glucocorticoid-induced pruritus will be useful for clarifying the mechanisms of the rebound phenomenon induced by chronic treatment with topical glucocorticoids, and for developing a new form of therapy.",
keywords = "Contact dermatitis, Dexamethasone, Nerve growth factor mRNA, Pruritus, Serum IgE, Topical glucocorticoid",
author = "Katsunori Yamaura and Ryosuke Doi and Eriko Suwa and Koichi Ueno",
year = "2011",
month = "8",
doi = "10.2131/jts.36.395",
language = "English",
volume = "36",
pages = "395--401",
journal = "Journal of Toxicological Sciences",
issn = "0388-1350",
publisher = "Japanese Society of Toxicological Sciences",
number = "4",

}

TY - JOUR

T1 - A novel animal model of pruritus induced by successive application of glucocorticoid to mouse skin

AU - Yamaura, Katsunori

AU - Doi, Ryosuke

AU - Suwa, Eriko

AU - Ueno, Koichi

PY - 2011/8

Y1 - 2011/8

N2 - Topical glucocorticoids are commonly applied for treatment of atopic dermatitis, and are often administered over a long period. However, itching often occurs as a rebound phenomenon after cessation of long-term glucocorticoid application. The present study was an initial trial designed to establish an animal model of glucocorticoid-induced pruritus by topical application of dexamethasone over a long period in mice with contact dermatitis. BALB/c mice with chronic allergic contact dermatitis induced by 5 weeks of repeated application of 2,4,6-trinitro-1-chlorobenzene (TNCB) were treated topically with dexamethasone for 3 weeks from 2 weeks after the elicitation of dermatitis. The effects of dexamethasone on inflammation and pruritus were evaluated by measurement of ear-swelling and scratching behavior, respectively. Significant enhancement of pruritus was confirmed after chronic application of dexamethasone. The increased frequency of scratching behavior was reduced by withdrawal of dexamethasone. On the other hand, ear-swelling was markedly ameliorated by dexamethasone treatment, but rapidly relapsed after dexamethasone withdrawal. The level of interleukin (IL)-4 mRNA in ear skin and that of IgE in serum were increased in the mice with dermatitis and reduced by dexamethasone treatment. On the other hand, the level of nerve growth factor (NGF) mRNA was slightly increased by dexamethasone treatment and remained high even after its discontinuation. It is anticipated that this novel animal model of glucocorticoid-induced pruritus will be useful for clarifying the mechanisms of the rebound phenomenon induced by chronic treatment with topical glucocorticoids, and for developing a new form of therapy.

AB - Topical glucocorticoids are commonly applied for treatment of atopic dermatitis, and are often administered over a long period. However, itching often occurs as a rebound phenomenon after cessation of long-term glucocorticoid application. The present study was an initial trial designed to establish an animal model of glucocorticoid-induced pruritus by topical application of dexamethasone over a long period in mice with contact dermatitis. BALB/c mice with chronic allergic contact dermatitis induced by 5 weeks of repeated application of 2,4,6-trinitro-1-chlorobenzene (TNCB) were treated topically with dexamethasone for 3 weeks from 2 weeks after the elicitation of dermatitis. The effects of dexamethasone on inflammation and pruritus were evaluated by measurement of ear-swelling and scratching behavior, respectively. Significant enhancement of pruritus was confirmed after chronic application of dexamethasone. The increased frequency of scratching behavior was reduced by withdrawal of dexamethasone. On the other hand, ear-swelling was markedly ameliorated by dexamethasone treatment, but rapidly relapsed after dexamethasone withdrawal. The level of interleukin (IL)-4 mRNA in ear skin and that of IgE in serum were increased in the mice with dermatitis and reduced by dexamethasone treatment. On the other hand, the level of nerve growth factor (NGF) mRNA was slightly increased by dexamethasone treatment and remained high even after its discontinuation. It is anticipated that this novel animal model of glucocorticoid-induced pruritus will be useful for clarifying the mechanisms of the rebound phenomenon induced by chronic treatment with topical glucocorticoids, and for developing a new form of therapy.

KW - Contact dermatitis

KW - Dexamethasone

KW - Nerve growth factor mRNA

KW - Pruritus

KW - Serum IgE

KW - Topical glucocorticoid

UR - http://www.scopus.com/inward/record.url?scp=79961158741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961158741&partnerID=8YFLogxK

U2 - 10.2131/jts.36.395

DO - 10.2131/jts.36.395

M3 - Article

C2 - 21804303

AN - SCOPUS:79961158741

VL - 36

SP - 395

EP - 401

JO - Journal of Toxicological Sciences

JF - Journal of Toxicological Sciences

SN - 0388-1350

IS - 4

ER -